Third Rock launches new cell therapy startup
Third Rock has launched a new cell-therapy startup looking to use T regulatory cells to combat autoimmune diseases like MS and diabetes — and it's got $95M and a partnership with ElevateBio to help get it going.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Rowan Walrath Source Type: news
More News: American Health | Autoimmune Disease | Diabetes | Endocrinology | Health Management | Partnerships